Altre lingue Alembic Pharmaceuticals Limited

Azioni

APLLTD

INE901L01018

Mercato chiuso - NSE India S.E. Altri mercati azionari 13:51:18 23/04/2024			Variaz. 5gg	Var. 1 gen.
940,2 ^INR	-1,24%		-2,92%	+23,81%

02/04	Alembic Pharmaceuticals nomina Manish Kejriwal come Direttore indipendente	CI
02/04	Alembic Pharmaceuticals riceve dalla FDA statunitense un cenno di approvazione provvisorio per il trattamento generico del cancro al seno	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	18/04
Alembic Pharmaceuticals Limited Received 3 Assessment Orders from the Office of Assistant Commissioner (ST), Andhra Pradesh	08/04
Alembic Pharmaceuticals Appoints Manish Kejriwal as Independent Director	02/04
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	02/04
Alembic Pharmaceuticals Limited Receives One US Food & Drug Administration Product Approval	01/04
Alembic Pharmaceuticals Limited Announces Board Cessations	01/04
Alembic Pharmaceuticals Limited Receives Order from Commission of Customs, Mumbai Zone- III	18/03
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA	11/03
Alembic Pharmaceuticals Limited Announces United States Food and Drug Administration Conducted an Inspection At Oncology Formulation Facility At Panelav	08/03
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	08/03
Indian shares seen muted tracking broader Asian equities	26/02
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	23/02
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	06/02
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	06/02
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	05/02
Alembic Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	05/02
Alembic Pharmaceuticals Limited Announces Designation of Manuj Desai as Head - It as Senior Management Personnel	05/02
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	05/01
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	03/01
Alembic Pharmaceuticals Receives Various Us Food & Drug Administration Product Approvals	01/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Alembic Pharmaceuticals Limited

Azioni

APLLTD

INE901L01018

Altre lingue

Filtri